Patents by Inventor Miguel F. Segura

Miguel F. Segura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9421218
    Abstract: Described herein are compositions and methods for the prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma or with melanoma brain tropism, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: April 13, 2011
    Date of Patent: August 23, 2016
    Assignee: New York University
    Inventors: Eva Hernando, Moshe Hoshen, Iman Osman, Avital Gaziel-Sovran, Miguel F. Segura
  • Publication number: 20140050803
    Abstract: Described herein are compositions and methods for the prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma or with melanoma brain tropism, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: April 13, 2011
    Publication date: February 20, 2014
    Applicant: NEW YORK UNIVERSITY
    Inventors: Eva Hernando, Moshe Hoshen, Iman Osman, Avital Gaziel-Sovran, Miguel F. Segura
  • Publication number: 20120322743
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: August 8, 2012
    Publication date: December 20, 2012
    Applicant: NEW YORK UNIVERSITY
    Inventors: Eva Hernando, Miguel F. Segura, Douglas Hanniford, Silvia Menendez
  • Patent number: 8252760
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: August 28, 2012
    Assignee: New York University
    Inventors: Eva Hernando, Miguel F. Segura, Douglas Hanniford, Silvia Menendez
  • Publication number: 20090238896
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: March 24, 2009
    Publication date: September 24, 2009
    Applicant: NEW YORK UNVERSITY
    Inventors: EVA HERNANDO, MIGUEL F. SEGURA, DOUGLAS HANNIFORD, SILVIA MENENDEZ